ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 257

Argentine Registry of Patients with Fibromyalgia

Julia Sosa1, Silvia Beatriz Papasidero2, Diana Silvia Klajn3, María Paula Kohan3, José Ángel Caracciolo4, Rosana Inés Trobo5, Cecilia Romeo6, Gustavo Casado6,7, Daniel Gilberto8, Juan Carlos Calcagno8, Gisela Pendón9, Federico Giordano10, Dora Pereira11, Alicia Munarriz12, Diaz Mónica13, Darío Scublinsky14, Analía Bohr15, A. Perez Davila16, Ingrid Petkovic17, Sandra Petruzzelli18, Julio Hofman19, Marta Silvia Espósito19, Virginia Ortiz19, Susana Visentini20, Ariel Vulcano21, Alejandra Beatriz Pringe22, Marcela Herrera Calvo23, María Hu24 and GESAR FM (Grupo de Estudio de la Sociedad Argentina de Reumatología)25, 1Rheumatology Section, Hospital General de Agudos Dr. Enrique Tornú, Argentina, CABA, Argentina, 2Rheumatology Department, Hospital General de Agudos Dr. Enrique Tornú, Buenos Aires, Argentina, 3Rheumatology Section, Hospital General de Agudos Dr. Enrique Tornú, CABA, Argentina, 4Rheumatology Section, Hospital General de Agudos Dr. Enrique Tornú, Buenos Aires, Argentina, 5Rheumatology Department, Hospital Nacional Dr. Baldomero Sommer, Buenos Aires, Argentina, 6Rheumatology Department, Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich, Buenos Aires, Argentina, 7Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich, Buenos Aires, Argentina, 8Rheumatology Department, Casa Hospital San Juan de Dios, Buenos Aires, Argentina, 9Hospital Dr. Ricardo Gutiérrez, La Plata, Argentina, 10Rheumatology Department, Hospital Dr. Ricardo Gutiérrez, La Plata, Buenos Aires, Argentina, 11Rheumatology Section, Hospital Dr. Ricardo Gutiérrez, Argentina, Buenos Aires, Argentina, 12Centro Médico Privado CENYR, San Luis, Argentina, 13Centro Traumatológico Bariloche, Rio Negro, Argentina, 14Clínica Suizo Argentina, Buenos Aires, Argentina, 15Rheumatology Section, Hospital de Rehabilitación Manuel Rocca, Buenos Aires, Argentina, 16Rheumatology, Hospital de Rehabilitación Manuel Rocca, Ciudad Autonoma de Buenos Aires, Argentina, 17Sanatorio Petkovic, Mendoza, Argentina, 18Casa Hospital San Juan de Dios, Buenos Aires, Argentina, 19Consultorio Privado, Buenos Aires, Argentina, 20Hospital Durand, Buenos Aires, Argentina, 21Rheumatology, HIGA General San Martin La Plata, la plata, Argentina, 22Rheumatology Department, Hospital de Niños Pedro de Elizalde, Buenos Aires, Argentina, 23Hospital de Niños Pedro de Elizalde, Buenos Aires, Argentina, 24Hospital Penna, Buenos Aires, Argentina, 25Sociedad Argentina de Reumatología, Argentina, Argentina

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Fibromyalgia and registry

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Fibromyalgia and Other Clinical Pain Syndromes Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Fibromyalgia (FM) has been reported in up to 5% of adult population and its treatment still represents a challenge. In Argentina, there are few records describing the different aspects of FM patients. Therefore, the aim of the study was to describe the frequency of FM patients consults in daily practice and to analyze these patient characteristics.

Methods: Multicenter, observational, cross-sectional study that included a total of 759 patients with FM (ACR 1990 and/or ACR 2010 criteria). The number of consultations performed from January to June of 2017 (both the total consultations and those of patients with FM) was recorded. For each patient with FM, we collected the following data: age, gender, health insurance provider, whether it was the first time consulting a physician, professional who referred the patient, duration of FM, presence of concomitant autoimmune disease, comorbidities and treatment. Statistical analysis: Descriptive analyses of the clinical characteristics were performed, using absolute numbers and proportions for categorical variables, and means and medians, standard deviation (SD) and interquartile range (IQR) for numerical variables. Frequency of FM consultations with the corresponding 95% confidence interval was determined. We compared demographic and disease characteristics according to health insurance provider, public care and presence of comorbidities by means of chi-square or T-student test.

Results: A total of 759 patients (12 children) from 15 rheumatology centers were included. According to the complete registries from 6 centers, from a total of 7350 visits in a 6-month period, the frequency of FM patients consults was 10.4% (CI95 9.7-11.1). Out of 747 adult patients, 95% were women, median age 52 (SD 12.6), 9% were consulting for the first time and 78% had a health insurance. Median duration of FM was 24 months (IQR 10-48). Most patients resulted from referrals from General Practice (54%) and Traumatology (28%). About 28% of the patients have a concomitant autoimmune disease, being RA and Hypothyroidism present in more than 30% of the cases. Hypertension and Osteoarthritis were the most frequent comorbidities reported. Most patients (96%) were on pharmacological treatment (80% Pregabalin). The most frequent non-pharmacological treatments were kinesiotherapy (40%) and physical activity (27%). Patients from the public health system (36%) showed higher probability of being referred by other specialists (69 vs 48%, p<0.001), longer duration of FM (55 vs 32 months, p<0.0001) and less number of doctors previously consulted (2 vs 3, p<0.0001). Out of 12 pediatric patients (all referred by other specialists), 11 were girls, mean age 13 (SD 3). Median duration of symptoms was 10 months (ICQ 7-48); 75% were treated with NSAIDs and 25% with Pregabalin; 92% were on kinesiotherapy and 85% on psychotherapy.

Conclusion: Until the date, this is the largest Argentine registry of FM patients, including a large number of patients (both adult and pediatric) and many participating centers. We believe that this registry could provide evidence-based socio-demographic data, useful not only for clinical trials but also to improve treatment strategies in FM.


Disclosure: J. Sosa, None; S. B. Papasidero, None; D. S. Klajn, None; M. P. Kohan, None; J. Á. Caracciolo, None; R. I. Trobo, None; C. Romeo, None; G. Casado, None; D. Gilberto, None; J. C. Calcagno, None; G. Pendón, None; F. Giordano, None; D. Pereira, None; A. Munarriz, None; D. Mónica, None; D. Scublinsky, None; A. Bohr, None; A. Perez Davila, None; I. Petkovic, None; S. Petruzzelli, None; J. Hofman, None; M. S. Espósito, None; V. Ortiz, None; S. Visentini, None; A. Vulcano, None; A. B. Pringe, None; M. Herrera Calvo, None; M. Hu, None; G. F. (Grupo de Estudio de la Sociedad Argentina de Reumatología), None.

To cite this abstract in AMA style:

Sosa J, Papasidero SB, Klajn DS, Kohan MP, Caracciolo JÁ, Trobo RI, Romeo C, Casado G, Gilberto D, Calcagno JC, Pendón G, Giordano F, Pereira D, Munarriz A, Mónica D, Scublinsky D, Bohr A, Perez Davila A, Petkovic I, Petruzzelli S, Hofman J, Espósito MS, Ortiz V, Visentini S, Vulcano A, Pringe AB, Herrera Calvo M, Hu M, (Grupo de Estudio de la Sociedad Argentina de Reumatología) GF. Argentine Registry of Patients with Fibromyalgia [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/argentine-registry-of-patients-with-fibromyalgia/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/argentine-registry-of-patients-with-fibromyalgia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology